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Whatever does not exist does not have a name 
(African proverb).
A 
new survey conducted by 
Emmanuel Addo-Yobo and 
colleagues, and published in 
PLoS Medicine [1], shows an increase in 
the prevalence of asthma and allergic 
diseases in children in Ghana between 
1993 and 2003. In this essay, we discuss 
the context for this new study by 
exploring what is known about the 
epidemiology of asthma in Africa.
Research on Asthma in Africa
Looking at about 120 papers from 
Medline on asthma in Africa, we found 
that asthma research is currently 
dominated by authors from South 
Africa, followed by authors from 
Nigeria, Tanzania, Ethiopia, Kenya, 
and The Gambia. Most are case 
studies, closely followed by cross-
sectional studies, and then case-control 
studies. There have been very few 
cohort studies. Only a few studies use 
objective measures [2,3], which makes 
the new PLoS Medicine study unusual, 
since the researchers used repeated 
measurements of skin prick tests and 
bronchial reactivity [1].
Clinical Features and Risk Factors
The clinical presentation of asthma in 
Africa does not seem to be different 
from other parts of the world [4], 
although one study reports later 
disease onset in Africa [5]. Assumed 
risk factors are local ﬂ  ora such 
as Kikuyu grass, Makaore cherry, 
Tanganyika aningré, and Der néré 
as well as helminthic infection by 
Trichuris, Schistosoma, Ascaris, and 
hookworm (Figure 1). Well-known 
allergens in Africa are house dust mite, 
cockroach, and cat and dog dander; 
a less well known allergen is washing 
soap. Parental history, female sex, low 
physical activity, and malnutrition, have 
been described as risk factors together 
with pesticides, insecticides, wood or 
kerosene heating, grass mats, mud and 
cow dung, smoking, and car and truck 
diesel exhaust. In the occupational 
setting isocyanate and latex sensitivity 
have been reported as risk factors, 
and poultry workers, hairdressers, 
gold miners, and wood choppers are 
reported as having an increased risk of 
asthma. Annual rainfall seems to have 
an inﬂ  uence on symptom presentation.
Despite the risk factors discussed 
above, there is no overall hypothesis to 
explain asthma causation in Africa. In 
one study, traditional healers in Dar 
es Salaam, Tanzania were convinced 
that asthma is caused by “ingestion of 
amniotic ﬂ  uid during birth” (83%), 
by “God” (75%), or “one inherits 
[asthma] from parents” (73%) [6]. 
Traditional asthma remedies are 
usually tried without major success 
[7] although some may contain 
pharmacologically active substances 
[8].
Prevalence Rates
Intercountry prevalence data are 
limited to the International Study of 
Asthma and Allergies in Childhood 
(ISAAC, http:⁄⁄isaac.auckland.ac.nz) 
in which seven African countries 
participated (English-speaking regions: 
Ethiopia 9.1%, Kenya 15.8%, Nigeria 
13.0%, and South Africa 20.3%; and 
French-speaking regions: Algeria 
8.7%, Morocco 10.4%, and Tunisia 
11.9% [9]). Symptom rates are lower 
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Figure 1. Hookworms (Ancylostoma caninum) Attached to the Intestinal Mucosa
Barely visible larvae penetrate the skin (often through bare feet), are carried to the lungs, migrate 
through the respiratory tract to the mouth, are swallowed, and eventually reach the small intestine. 
This journey takes about a week. (Photo: Centers for Disease Control)
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than in industrialized countries, while 
only South Africa approaches rates 
found in the UK. The interpretation 
of these ﬁ  gures, however, is difﬁ  cult; 
there might be an increase with gross 
domestic product and industrialization 
factors [10]. Rural African regions 
always showed much lower asthma 
prevalence rates than urban areas [11]. 
People living in rural grasslands rarely, 
if ever, suffer from allergic diseases 
and some do not even have a term to 
describe this condition [12]. 
Genes or Environment?
As in industrialized countries asthma 
in Africa is determined by genes and 
environment. However, both genetic 
and environmental effects may operate 
in different directions and on different 
scales. 
The African environment is different 
from that in other parts of the world—
in Africa, not only climate but also air 
pollution reaches both extremes [13]. 
The spectrum of pathogens may also 
be different, with conﬂ  icting evidence 
on worm infection, IgE, and allergy. 
Recent research in Ethiopia concludes 
that “There was no reduction in the 
risk of AD [atopic dermatitis] in 
relation to intestinal parasite infection; 
in fact, AD was increased in subjects 
with Trichuris .... The risk of AD was 
also unrelated to family size, crowding 
in the home, or breast-feeding, but 
was related to previously unrecognized 
factors including malaria and access to 
piped drinking water” [14].
Public health experts have long 
argued that “ingestions of unsafe water, 
inadequate availability of water for 
hygiene, and lack of access to sanitation 
contribute to 1,5 million child deaths” 
[15]. But how may deaths from unsafe 
water relate to allergy and asthma? 
Although it may seem counterintuitive 
at ﬁ  rst, changes in the African gene 
pool could provide an answer to this 
question. The concern is not about 
ethnic differences in asthma-related 
genes [16–19], although these clearly 
exist. Gene sequence in Africans is 
more diverse, showing many more 
variants [20], but even that may not be 
a key point. Profound changes in the 
gene pool may be caused by changes 
in childhood mortality [21]. At the 
beginning of the last century acute 
respiratory infections in Europe had 
been the main reason for childhood 
death, causing many children to die 
before reaching reproductive age. 
Vaccination programs, better nutrition, 
and antibiotic treatment, however, 
have reduced mortality from acute 
respiratory infection while the asthma 
incidence increased at the same time. 
Safe water [14] and antibiotic use 
[22] could therefore be indicators of 
a suppression of natural or purifying 
selection. 
This suppression may have enormous 
consequences on a population level: 
In Europe, mortality under the age of 
5 years was about 250/1,000 live-born 
children in 1900, dropped to 50 around 
1950, and is now about ﬁ  ve [21]. In 
sub-Saharan Africa in 2000, there are 
still 175 deaths per 1,000 live births 
[15]; Addo-Yobo et al. report a decline 
from 69/1,000 to 55/1,000 live births 
during the study period [1]. Can these 
differences in childhood mortality 
explain the extremes of virtually no 
asthma up to a prevalence of 20%? 
This seems a testable hypothesis where 
even the rise or fall of gene variants 
in immune defence genes could be 
monitored. Or do environmental 
factors play a central role? Or is this 
increase a complex melange of all of 
the variables?
As of the 1980s, there was an 
overall conviction that asthma 
had an anthropogenic origin with 
indoor and outdoor air pollution as 
the main culprits. Following some 
overinterpreted epidemiological 
ﬁ  ndings of the “hygienic” phase, there 
is now evidence accumulating that 
the asthma epidemic might have an 
iatrogenic origin [23]. There might 
not only be indirect effects of improved 
living standards and better medical 
care, there are even direct effects under 
discussion, for example by oestrogens 
[24], vitamin D [25], antibiotics [22], 
and paracetamol [26]. Infant formula 
(which contains vitamin D) has already 
entered the food chain in Africa [5]; 
paracetamol is the most common 
drug bought over the counter in 
Ghana (E. O. D. Addo-Yobo, personal 
communication, 2006). Do African 
countries offer any unique observations 
where singular effects of these drugs 
can be delineated?
Conclusion
Given the large African continent, its 
enormous health problems, and its 
poverty, there needs to be a shift in 
donor countries’ funding priorities 
[27]. We believe that this shift might be 
even in the interest of the developed 
countries that are now suffering 
from high rates of asthma [9], since 
major characteristics of traditional 
lifestyle have changed irrespective of 
socioeconomic status. Many African 
societies are still going through 
the early stages of the transition to 
urbanised economies, leaving us all 
opportunities to look for the factors 
driving early sensitisation and later 
asthma [27]. In that respect Africa 
probably has more to offer than any 
study in the developed world.  
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